KURA
Kura Oncology Inc
10.70$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 16.9% | – | – | – | 0.4% | 0.0% | 1.5% | 15.5% | 2.7% | 3.4% | 1.2% | 5.9% | |
| – | -16.9% | – | – | – | 100.0% | 100.0% | 100.0% | 84.5% | 100.0% | 96.6% | 98.8% | 94.7% | |
| – | 2,561.7% | – | – | – | 97.0% | 396.7% | 410.7% | 327.3% | 371.5% | 357.3% | 296.5% | 336.0% | |
| – | 1,120.4% | – | – | – | 44.7% | 161.9% | 164.6% | 158.3% | 225.8% | 172.8% | 152.1% | 175.2% | |
| – | 3,665.2% | – | – | – | 141.7% | 558.6% | 575.3% | 470.0% | 597.6% | 528.1% | 448.6% | 506.6% | |
| – | -3,682.0% | – | – | – | -41.7% | -458.6% | -475.3% | -385.5% | -497.6% | -431.5% | -349.8% | -411.9% | |
| – | 31.0% | – | – | – | 0.7% | 2.7% | 2.6% | 1.9% | 2.0% | 1.8% | 1.7% | 1.8% | |
| – | -3,369.0% | – | – | – | -31.9% | -405.5% | -432.5% | -357.2% | -466.8% | -401.5% | -327.3% | -384.2% | |
| – | 226.5% | – | – | – | 3.7% | 1.6% | – | – | 0.4% | 0.0% | 0.0% | – | |
| – | -3,369.0% | – | – | – | -35.7% | -407.1% | -432.5% | -357.2% | -467.2% | -401.5% | -327.3% | -384.3% | |
| – | -3,321.1% | – | – | – | -30.8% | -406.5% | -428.5% | -356.4% | -462.5% | -397.7% | -314.3% | -378.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.